Please Wait.....
Report
Antitussive Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs, Others), By Route of Administration (Inhalational, Oral, Others), By Age Group (Geriatric, Pediatric, Adult), By End-User (Homecare, Hospitals & Specialty Clinics, Others), By Region & Competition, 2020-2030F
Market Report I 2025-04-11 I 180 Pages I TechSci Research
Global Antitussive Drugs Market was valued at USD 1.60 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.20% through 2030. The Global Antitussive Drugs Market is experiencing sustained growth, primarily driven by the rising prevalence of respiratory diseases, an expanding elderly population, and improved healthcare accessibility. Antitussive drugs, or cough suppressants, are essential in managing acute and chronic coughs linked to conditions such as upper respiratory tract infections (URTIs), chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and post-viral syndromes.
This market benefits from strong consumer demand for both over-the-counter (OTC) and prescription-based antitussive medications, with major contributions from leading pharmaceutical corporations and emerging industry players. Ongoing research and development (R&D) efforts, alongside advancements in drug formulations, are shaping competitive dynamics and fostering product innovation.
Key Market Drivers
Rising Prevalence of Respiratory Diseases
The rising prevalence of respiratory diseases is one of the most significant drivers fueling the expansion of the Global Antitussive Drugs Market. With an increasing number of people experiencing respiratory illnesses, the demand for cough suppressants and related medications is witnessing steady growth. Each year, chronic obstructive pulmonary disease (COPD) claims over 3 million lives, yet it remains significantly underprioritized in global healthcare discussions. Affecting more than 380 million people worldwide, COPD is the fourth leading cause of death, imposing a severe economic and healthcare burden. Despite its widespread impact on patients, caregivers, and healthcare systems, the disease continues to receive disproportionately low attention and funding compared to other major noncommunicable diseases. Chronic and acute respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, pneumonia, tuberculosis (TB), and post-viral cough syndromes, are becoming more prevalent worldwide. In 2023, tuberculosis (TB) affected an estimated 10.8 million people globally, including 6.0 million men, 3.6 million women, and 1.3 million children, highlighting its widespread impact across demographics. Present in every country and affecting all age groups, TB continues to pose a significant public health challenge. These conditions often manifest with persistent coughing, requiring effective antitussive (cough suppressant) treatments.
Key Market Challenges
Regulatory Hurdles and Stringent Approvals
One of the primary challenges in the antitussive drugs market is the rigorous regulatory environment governing pharmaceuticals. To ensure safety and efficacy, regulatory agencies such as the FDA (U.S. Food and Drug Administration) and the EMA (European Medicines Agency) impose stringent approval processes for new antitussive drugs.
Developing and bringing a new antitussive drug to market involves extensive clinical trials, data submission, and regulatory reviews. The process is time-consuming and costly, with no guarantee of approval. Companies may face delays, increased development costs, or even the rejection of their drug candidates, impacting market entry.
Key Market Trends
Shift Towards Non-Opioid and Non-Codeine Formulations
One of the prominent trends in the antitussive drugs market is the increasing preference for non-opioid and non-codeine formulations. This shift is primarily driven by concerns related to the addictive potential and side effects associated with opioid-based antitussive drugs.
Regulatory Scrutiny: Regulatory agencies like the FDA have imposed stricter controls and monitoring of opioid-based medications due to their potential for abuse and addiction. This has led to a reduced appetite among healthcare providers to prescribe such drugs. Patient Safety: Patient safety and minimizing the risk of opioid misuse have become paramount concerns. Non-opioid alternatives are seen as safer options for managing coughing, especially in pediatric and vulnerable patient populations.
Advances in pharmaceutical research have led to the development of non-opioid antitussive medications that offer comparable efficacy in suppressing coughing without the risk of opioid-related complications. This has fueled the market demand for non-opioid alternatives.
Key Market Players
- Teva Pharmaceutical Industries Ltd.
- Intas Pharmaceuticals Ltd.
- Bayer AG
- Ipca Laboratories Ltd.
- F. Hoffmann-La Roche Ltd.
- Hikma Pharmaceuticals PLC
- Unique Pharmaceuticals Limited
- Cipla Inc.
- Viatris Inc.
- Aurobindo Pharma
Report Scope:
In this report, the Global Antitussive Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Antitussive Drugs Market, By Drug Class:
o Peripherally Acting Drugs
o Centrally Acting Drugs
o Others
- Antitussive Drugs Market, By Route of Administration:
o Inhalational
o Oral
o Others
- Antitussive Drugs Market, By Age Group:
o Geriatric
o Pediatric
o Adult
- Antitussive Drugs Market, By End-User:
o Homecare
o Hospitals & Specialty Clinics
o Others
- Antitussive Drugs Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Antitussive Drugs Market.
Available Customizations:
Global Antitussive Drugs market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Antitussive Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs, Others)
5.2.2. By Route of Administration (Inhalational, Oral, Others)
5.2.3. By Age Group (Geriatric, Pediatric, Adult)
5.2.4. By End-User (Homecare, Hospitals & Specialty Clinics, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Antitussive Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Route of Administration
6.2.3. By Age Group
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Antitussive Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Route of Administration
6.3.1.2.3. By Age Group
6.3.1.2.4. By End User
6.3.2. Canada Antitussive Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Route of Administration
6.3.2.2.3. By Age Group
6.3.2.2.4. By End User
6.3.3. Mexico Antitussive Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Route of Administration
6.3.3.2.3. By Age Group
6.3.3.2.4. By End User
7. Europe Antitussive Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Route of Administration
7.2.3. By Age Group
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Antitussive Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Age Group
7.3.1.2.4. By End User
7.3.2. United Kingdom Antitussive Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Age Group
7.3.2.2.4. By End User
7.3.3. Italy Antitussive Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Age Group
7.3.3.2.4. By End User
7.3.4. France Antitussive Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Route of Administration
7.3.4.2.3. By Age Group
7.3.4.2.4. By End User
7.3.5. Spain Antitussive Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Route of Administration
7.3.5.2.3. By Age Group
7.3.5.2.4. By End User
8. Asia-Pacific Antitussive Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Route of Administration
8.2.3. By Age Group
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Antitussive Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Age Group
8.3.1.2.4. By End User
8.3.2. India Antitussive Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Age Group
8.3.2.2.4. By End User
8.3.3. Japan Antitussive Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Age Group
8.3.3.2.4. By End User
8.3.4. South Korea Antitussive Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By Age Group
8.3.4.2.4. By End User
8.3.5. Australia Antitussive Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By Age Group
8.3.5.2.4. By End User
9. South America Antitussive Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Route of Administration
9.2.3. By Age Group
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Antitussive Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Age Group
9.3.1.2.4. By End User
9.3.2. Argentina Antitussive Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Age Group
9.3.2.2.4. By End User
9.3.3. Colombia Antitussive Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Age Group
9.3.3.2.4. By End User
10. Middle East and Africa Antitussive Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Route of Administration
10.2.3. By Age Group
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Antitussive Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By Age Group
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Antitussive Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By Age Group
10.3.2.2.4. By End User
10.3.3. UAE Antitussive Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Class
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By Age Group
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Antitussive Drugs Market: SWOT Analysis
14. Competitive Landscape
14.1. Teva Pharmaceutical Industries Ltd.
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Intas Pharmaceuticals Ltd.
14.3. Bayer AG
14.4. Ipca Laboratories Ltd.
14.5. F. Hoffmann-La Roche Ltd.
14.6. Hikma Pharmaceuticals PLC
14.7. Unique Pharmaceuticals Limited
14.8. Cipla Inc.
14.9. Viatris Inc.
14.10.Aurobindo Pharma
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security